pharmacy practice advancement: policy influences at … · 2017-05-12 · pharmacy practice...

14
5/12/17 1 Pharmacy Practice Advancement: Policy Influences at the National Level C. EDWIN WEBB, PHARM.D., M.P.H. FERRIS STATE UNIVERSITY SPRING SEMINAR MAY 16, 2017 1 Disclosure I have no actual or potential conflicts of interest in relation to this activity. 2 Learning Objectives Recognize opportunities for pharmacy practice advancement presented by national shifts in payment policy and benefit design to reward “value and outcomes” rather than “volume” of health care services. Define the key principles of patient-centered and team-based care that facilitate improved clinical, economic, and quality outcomes from the use of medications. Explain the emerging national trends in standardized direct patient care processes for pharmacists and their potential to support contemporary practice advancement. 3

Upload: dinhdien

Post on 10-Jun-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

1

PharmacyPracticeAdvancement:PolicyInfluencesattheNationalLevel

C.EDWINWEBB,PHARM.D.,M.P.H.

FERRISSTATEUNIVERSITYSPRINGSEMINAR

MAY16,2017

1

Disclosure• Ihavenoactualorpotentialconflictsofinterestinrelationtothisactivity.

2

LearningObjectives• Recognizeopportunitiesforpharmacypracticeadvancementpresentedbynationalshiftsinpaymentpolicyandbenefitdesigntoreward“valueandoutcomes”ratherthan“volume”ofhealthcareservices.• Definethekeyprinciplesofpatient-centeredandteam-basedcarethatfacilitateimprovedclinical,economic,andqualityoutcomesfromtheuseofmedications.• Explaintheemergingnationaltrendsinstandardizeddirectpatientcareprocessesforpharmacistsandtheirpotentialtosupportcontemporarypracticeadvancement.

3

Page 2: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

2

“AssumedTruths”inHealthCareReformPaymentReform:â FFSandá “bundles”,quality/outcomesincentives

Patient-centeredness(e.g.,fromboomerstomillennials)Healthcareteams,PCMH’s,andACO’s

Risksharing– oneandtwo-sided

Proactiveanalysisofandcareforpopulations

Technologyinnovationsandadaptations◦ precisionmedicine◦ pharmacogenomics◦ clinicaldecisionsupportusingevidence-basedstandards◦ health-IT– shifttointeroperability

MACRA2015– gamechangerformedicine18thtimeisacharm:MACRArepealsthe1997sustainablegrowthrateforPartBpaymentsReplacestheSGRwithanewpaymentmethodmeanttomovephysiciansandsomeotherproviderstowardalternativepaymentmodels(APMs)MACRAcreatestwoavailabletracks◦MIPS:“fee-for-serviceplusqualitylink”◦ APMs:accountablecareorganizationorotherrisk-bearingorganization

5

Page 3: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

3

Whatispatient-centeredcare?“Theexperience(totheextenttheinformed,individualpatientdesiresit)oftransparency,individualization,recognition,respect,dignity,andchoiceinallmatters,withoutexception,relatedtoone’sperson,circumstances,andrelationshipsinhealthcare.”

DonaldBerwick,M.D.FormerCMSAdministratorPresident,InstituteforHealthcareImprovementHealthAffairs,August2009

9

Page 4: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

4

Anyrecent“significant”experienceasa“real”patient?

StopandReflect

•Whatwasitlike?•Didyoufeel:•Fullyinformedaboutyourdiagnosisandcareplan?•Includedindiscussions/decisionsaboutyourcare?•Empowered/expectedtoquestionanddiscuss?•Respected/valuedasanindividual?•Partoftheteam’sstructure/activities?

10

Whatisteam-basedcare?

“Thehealthcarewewanttoprovideforthepeopleweserve—safe,high-quality,accessible,person-centered—mustbeateameffort.Nosinglehealthprofessioncanachievethisgoalalone.”

CarolA.Aschenbrener,M.D.ThenExecutiveVicePresident

AssociationofAmericanMedicalColleges- 2011

11

IOMPaper“TeamMembers”

PamelaH.MitchellUniversityofWashington

MatthewK.WyniaAmericanMedicalAssociation

SallyOkunPatientsLikeMe

C.EdwinWebbAmericanCollegeofClinicalPharmacy

RobynGoldenRushUniversityMedicalCenter

BobMcNellisAmericanAcademyofPhysicianAssistants(former)

AgencyforHealthcareQualityandResearch

IsabelleVonKohorn,InstituteofMedicine(former)ValerieRohrbach,InstituteofMedicine

Page 5: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

5

IOMDiscussionPaper2012:Aframingdefinition

Team-basedhealthcareistheprovisionofhealthservicestoindividuals,families,and/ortheircommunitiesbyatleasttwohealthproviderswhoworkcollaborativelywithpatientsandtheircaregivers—totheextentpreferredbyeachpatient—toaccomplishsharedgoalswithinandacrosssettingstoachievecoordinated,high-qualitycare.

IOMDiscussionPaper2012:NecessaryPrinciplesofHigh-PerformingTeams• SharedGoals

• Clear(Distinct)Roles

• MutualTrust

• EffectiveCommunication

• MeasureableProcessesandOutcomes

IOMDiscussionPaper2012:Necessaryvaluesofsuccessfulteammembers

• Honesty

• Discipline

• Creativity

• Humility

• Curiosity

Page 6: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

6

So???…..whatdoesallthishavetodowith“real”pharmacypractice?

16

MTMDefined:Profession’sConsensus2005

“MTMisaserviceorgroupofservicesthatoptimizetherapeuticoutcomesforindividualpatients.MTMservicesincludemedicationtherapyreviews,pharmacotherapyconsults,anticoagulationmanagement,immunizations,healthandwellnessprogramsandmanyotherclinicalservices.PharmacistsprovideMTMtohelppatientsgetthebestbenefitsfromtheirmedicationsbyactivelymanagingdrugtherapyandbyidentifying,preventingandresolvingmedication-relatedproblems.”

17

MTMDefined:CMS,MedicarePartDMTMgenerallyreferstoactivitiesintendedtooptimizetherapeuticoutcomesbyensuringthatpatientsaretakingtheirmedicationssafelyandasprescribed,addressinganybarrierstotheirdoingso,andbringinganymedicationissuestotheattentionofthetreatingphysician.

Under423.153(d),aPartDsponsormustestablishanMTMprogramthat:◦ EnsurescoveredPartDdrugsareusedtooptimizetherapeuticoutcomesthroughimprovedmedicationuse,

◦ Reducestheriskofadverseevents,◦ Isdevelopedincooperationwithlicensedandpracticingpharmacistsandphysicians,◦ Maybefurnishedbypharmacistsorotherqualifiedproviders.

18

Page 7: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

7

CMSperspectiveonPartDMTM- ~2015“EvidencesuggeststhattheMTMservicescurrentlyofferedbyPartDplansfallshortoftheirpotentialtoimprovequalityandreduceunnecessarymedicalexpenditures,mostlikelyduetomisalignedfinancialincentivesandregulatoryconstraints.CompetitivemarketdynamicsandPartDprogramrequirementsandmetricsmayincentivizeinvestmentintheseactivitiesonlyatalevelnecessarytomeettheminimumcompliancestandards.”

“Currently,PartDstatutoryandregulatoryMTMprovisionsrequireuniformserviceofferingstoenrolleeswhomeettheplan’sprogramcriteria,basedonnumbersofmedicationsandchronicconditionsandexpectedannualprescriptiondrugcosts.Thesecriteriabothover-identifyandunder-identifybeneficiarieswhoareeitherexperiencingorat-riskofexperiencingmedication-relatedissuesandcouldbenefitfromMTMinterventions.”

“TheresultisthatPartDMTMprogramsmaynotincludethelevelofresourcesnorthetypeofactivitiesthatcouldhavethegreatestpositiveeffectonbeneficiaryoutcomes.”

19

PCPCCdefinescomprehensivemedicationmanagement(CMM)- 2012ThePCPCCguidedefinescomprehensivemedicationmanagementinthePCMH

IncludedinAHRQ’sInnovationCenter-QualityToolkit

2ndRevisionwithAppendixA-GuidelinesforPracticeandGuidelinesforDocumentation

PCPCCResourceGuide:IntegratingComprehensiveMedicationManagementtoOptimizePatientOutcomeshttp://www.pcpcc.net/files/medmanagement.pdf

CMMDefined:PCPCCComprehensivemedicationmanagementisdefinedas thestandardofcarethatensureseachpatient’smedications(whethertheyareprescription,nonprescription, alternative,traditional,vitamins,ornutritionalsupplements)areindividuallyassessedtodeterminethateach medicationisappropriateforthepatient,effectivefor themedicalcondition,safegiventhecomorbiditiesand othermedicationsbeingtaken,andabletobetakenby thepatientasintended.

Comprehensivemedication managementincludesanindividualizedcareplanthat achievestheintendedgoalsoftherapywithappropriate follow-uptodetermineactualpatientoutcomes.Thisall occursbecausethepatientunderstands,agreeswith, andactivelyparticipatesinthetreatmentregimen,thus optimizingeachpatient’smedicationexperienceand clinicaloutcomes.

PCPCCResourceGuide:IntegratingComprehensiveMedicationManagementtoOptimizePatientOutcomeshttp://www.pcpcc.net/files/medmanagement.pdf

Page 8: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

8

22

“ProviderStatus”An“experiencedcontrarian’s”viewpointWewouldhavehadtolooklongandhardtofindamore“tone-deaf”termforthemajorissueathandforpharmacists- effectivecoverage/paymentforpharmacists’patientcareservices- inrelationshiptothecurrentpolicyanddeliverysystemissuesjustoutlined– butthingsmaybestartingtochangeabit.

Tosucceed,theeffortmustbegroundedinacommitmenttopatients’care,outcomesandquality,nottoourownprofessional“status”…..itcan’tbeaboutUS!

Asanisolatedgoal,achieving“providerstatus”guaranteestheprofessionverylittle(seeMurawski andIves,AJHP2011,JAPhA 2013)

Asan“integrated”partofbroaderpracticechange andpaymentpolicychange,itcanhelppositionpharmaciststoactuallybemeaningfulandeffective“providers”

23

24

Page 9: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

9

RelevantExistingApproachesSection1861oftheSSA– the“holygrail”◦ Physician“definition”vs.physician“services”◦ Non-physician“providers”◦ StatutefocusesFIRSTontheservicescovered(PAIDFOR!!!)bythePartBbenefit,followingby“qualifications”description

NPsandPAs CSWPTServices Ph.D.PsychologistOTServices CRNA

UltimateIrony– a“providerofservices”means“….ahospital,criticalaccesshospital,skillednursingfacility,comprehensiveoutpatientrehabilitationfacility,homehealthagency,hospiceprogram,or,forpurposesofsection1814(g) andsection1835(e),afund.”

25

RelevantExistingApproachesState-based– IsitCDTM,“mid-level”or“providerstatus”?◦ NorthCarolina(2000)– “clinicalpharmacistpractitioner”◦ JointRegulatoryoversightbyBOP&BOM◦ Differentiatedtrainingandcredentialingrequirements◦ Protocolrequirements

◦ NewMexico(1993)– “pharmacistclinician”◦ Primarily“prescriptiveauthority”initiative◦ Requiresdiagnosticandphysicalassessmenttrainingequivalenttoaphysician’sassistant(includedinrevisedPharm.D.curriculum)

◦ Directsupervisionofasinglephysician◦ Policysupportoutsideofpharmacyduetoconcernsaboutaccessto“primarycare”

26

RelevantExistingApproachesCalifornia’s“Solution”(2013)– alesson?◦ Amendsthe“businessandprofessionalcode”todesignateallpharmacistsashealthcareproviders◦ Someprogressivemodificationstogeneralscopeofpractice◦ Establishes“advancedpracticepharmacist”◦ Education,trainingand/orspecialistcertificationrequirementsbeyondlicensure◦ Expandedscopeofpractice,notlimitedtoapharmacysetting◦ Regulatoryframeworknowessentiallycomplete

27

Page 10: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

10

So…whatarewestillmissing…?Withverylimitedexceptions,healthinsurancecoverageandpaymentpoliciesdon’texplicitlyincludemedicationmanagementservicesasadefinedbenefit fordiscreetPAYMENT!Aclearlydefined“what”deliveredusingaconsistentandstandardizedprocessofcareMorecompleteunderstandingthatcurrent trendsinpaymentpolicywillincreasethe“valueovervolume”challengeforALLproviders…andthefuture isnolongerfaraway

28

ProcessofDirectPatientCare:Towardstandardizationandalignment….

29

Pharmacyorganizations’harmonizationefforts:EnhancedstandardizationandprofessionalscopeofCPA/CDTMregulationsatthestatelevel;Recommendedguidelinesforthedevelopmentanduseof“statewideprotocols”(SWP’s)toimproveaccesstoproductsandcareservicesthataddressimportantpublichealthissuesthatmostpharmacistsareabletoprovide;Strivingforgreaterprecisionandrigorinterminologyreflectingpharmacists’patientcarepracticeactivities;

30

Page 11: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

11

Doyouknowthisman?

31Photocopyright2012- DreamWorksStudios

“Roles”vs.ResponsibilitiesSomequotesfromtheLindaStrandKeynoteatACCP2012:

“‘Linda,whenwhatyoudolookslikepatientcare,soundslikepatientcareandispatientcare,thenIwillpayyouforpatientcare.’”

(BCBSMinnesotaexecutive– circa1995)

“Eachofusdevelopedourownclinicalactivities,whichwedefinearoundourselves,basedonourspecialintereststhatemphasizeourstrengths,deliveredonourpreferredtimetable.Thatisnotapatientcareservice- thatisahobby.”

(Onthe“earlyhistory”ofclinicalpharmacy)

32

Responsibilitiesof“Providers”Aphilosophygroundedinanethicalframeworkthatputspatients/familiesatthecenterofone’spractice

Clinicalperformancethatisevidence-based,continuouslyaccessible,andrigorouslyconsistentinitsprocessofcare

Aprocessofcarethatisstandards-based,recognizable,andunderstoodbypatientsandtheteam

Apracticeinfrastructurethatassuresavailability/exchangeofessentialclinicaldata,unfailingdocumentationofcare,measuresresults,andvalidatesvaluesufficienttojustifypayment

33

Page 12: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

12

WhatSuccessMustLookLikeinaPharmacist’sDirectPatientCarePracticeTheservicecanbedescribedsimplyandintermsofwhatitcandoforthepatientTheservicehasanethicalandfiducialfoundationTheserviceisbasedonstandards ofpracticesothatitcanbedeliveredconsistently-- onepractitionertothenext-- andfromonepatienttothenextTheserviceintegrateswiththeotherprovidersonthehealthcareteam,usingalignedandconsistentterminology,philosophy,standardizedcareprocesses,andquality/outcomeemphasisTheservicegeneratesmeasureable,reproducibleresultsthatdemonstratevaluetoothersTheserviceispaidforasotherdirectpatientcareispaidfor(increasinglyincludingemergingvalue-basedpaymentmodels)

34

Inthefinalanalysis,“providers”must…befullyaccountableforthecareandservicestheyprovide,particularlyintermsofqualityandoutcomes;…becommittedtoandfocusedonthepatients/familywhohavegiventhempermission tocomeintotheirlives;…delivercareandservicesinthecontextofandalignmentwithnationalhealthpolicygoalsandobjectives;and…OWN andACCOMPLISH THEWORKthatisthecore oftheirparticularexpertise….whilenotaddingworktotheothercliniciansonthecareteam.

35

36

Get The MedicationsRight!

Page 13: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

13

SupplementalResourcesforContinuingProfessionalDevelopment• KaiserFamilyFoundation(www.kff.org)• ExcellentdatasourceonMedicarepolicies,trends,expenditures

•NationalCommitteeonQualityAssurance(www.ncqa.org)• KeyorganizationinhealthsystemqualitymetricsdevelopmentandapplicationbyMedicare/privatepayers

• HealthAffairs(www.healthaffairs.org)• Leadingnationalhealthpolicyjournalcoveringthewidestrangeofhealthpolicy,deliverysystem,andpaymentissues.

37

38

Questions?

Pre-Test1.TheannouncedgoalsoftheCentersforMedicareandMedicaidServices(CMS)toshiftthevastmajorityofitspaymentstructureforphysicians’andotherproviders’servicestowardquality/value-basedperformanceareintendedtooccuroverthenext:

A. 6-12monthsB. 2-3years(correct)C. 5-10yearsD. 2decades

39

Page 14: Pharmacy Practice Advancement: Policy Influences at … · 2017-05-12 · Pharmacy Practice Advancement: Policy Influences at the National Level C ... CMS perspective on Part D MTM

5/12/17

14

Pre-Test2.Whichofthefollowingisnot consideredanessentialprincipleofhigh-performinghealthcareteams?

A. Financialaccountability(correct)

B. EffectivecommunicationsC. SharedgoalsD. Clearroles

40

Pre-Test3.Whichofthefollowingelementsofapharmacist’sstate-authorizedscopeofpracticewilllikelybeimpactedbycurrentnationaltrendsindeliverysystemandpaymentpolicyreforms?

A. FrequencyoflicensurerenewalB. RequirednumberofhoursofACPE-

approvedcontinuingeducationactivitiesC. Structureandefficiencyofcollaborative

practiceagreementsandclinicalprotocols(correct)

D. Increasesinthepharmacist-to-technicianratioallowedunderstateregulations

41